Sexual side effects of pharmacological treatments;La iatrogénie médicamenteuse en médecine sexuelle

Progres en Urologie

Volumn 23, Issue 9, 2013, Pages 804-810

  Giuliano, F ^a   Droupy, S ^b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Antidepressants; Female sexual dysfunction; Hormonal treatment; Male sexual dysfunction; Neuroleptics

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ADVERSE DRUG REACTION; ANTIDÉPRESSEURS; CHEMICALLY INDUCED DISORDER; DYSFONCTION SEXUELLE FÉMININE; DYSFONCTION SEXUELLE MASCULINE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL TREATMENT; HORMONOTHÉRAPIE; HUMAN; MALE; MALE SEXUAL DYSFUNCTION; NEUROLEPTICS; NEUROLEPTIQUES; PROSTATE DISEASE; SEXUAL DYSFUNCTION; SHORT SURVEY;

ANTIDÉPRESSEURS; ANTIDEPRESSANTS; DYSFONCTION SEXUELLE FÉMININE; DYSFONCTION SEXUELLE MASCULINE; FEMALE SEXUAL DYSFUNCTION; HORMONAL TREATMENT; HORMONOTHÉRAPIE; MALE SEXUAL DYSFUNCTION; NEUROLEPTICS; NEUROLEPTIQUES;

CENTRAL NERVOUS SYSTEM AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; PROSTATIC DISEASES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84879920449     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2013.01.008     Document Type: Short Survey

References (41)

1. Baumhäkel M., Schlimmer N., Kratz M., Hacket G., Jackson G., Böhm M. Cardiovascular risk, drugs and erectile function-a systematic analysis. Int J Clin Pract 2011, 65:289-298.
2. Ko D.T., Hebert P.R., Coffey C.S., Sedrakyan A., Curtis J.P., Krumholz H.M. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002, 288:351-357.
3. Giuliano F., Leriche A., Jaudinot E., Solesse de Gendre A. Prevalence of erectile dysfunction among 7689patients with diabetes, hypertension, or both. Urology 2004, 64:1196-1201.
4. Karavitakis M., Komninos C., Theodorakis P.N., Politis V., Lefakis G., Mitsios K., et al. Evaluation of sexual function in hypertensive men receiving treatment: a review of current guidelines recommendation. J Sex Med 2011, 8:2405-2414.
5. Grimm R.H., Grandits G.A., Prineas R.J., McDonald R.H., Lewis C.E., Flack J.M., et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Hypertension 1997, 29:8-14.
6. Manolis A., Doumas M. Antihypertensive treatment and sexual dysfunction. Curr Hypertens Rep 2012, 14:285-292.
7. Shindel A.W., Kishore S., Lue T.F. Drugs designed to improve endothelial function: effects on erectile dysfunction. Curr Pharm Des 2008, 14:3758-3767.
8. Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU International 2006, 97:34-38.
9. Rosen R., Altwein J., Boyle P., Kirby R.S., Lukacs B., Meuleman E., et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003, 44:637-649.
10. Costa P., Sarrazin B., Bressolle F., Colson M.H., Bondil P., Saudubray F. Efficiency and side effects of intracavernous injections of moxisylyte in impotent patients: a dose-finding study versus placebo. J Urol 1993, 149:301-305.
11. Giuliano F. Lower urinary tract symptoms and sexual dysfunction: a common approach. BJU Int 2008, 101:22-26.
12. Oelke M., Giuliano F., Mirone V., Xu L., Cox D., Viktrup L. Tadalafil or tamsulosin in the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia: a phase 3, multicenter, double-blind, randomized, placebo-controlled trial. Eur Urol 2012, 61:917-925.
13. Giuliano F. Medical treatments for benign prostatic hyperplasia and sexual function. BJU Int 2008, 102:8-12.
14. Roehrborn C.G., Kaplan S.A., Lepor H., Volinn W. Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH. Prostate Cancer Prostatic Dis 2011, 14:143-148.
15. Shimizu F., Taguri M., Harada Y., Matsuyama Y., Sase K., Fujime M. Impact of dry ejaculation caused by highly selective alpha1A-blocker: randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men. J Sex Med 2010, 7:1277-1283.
16. Carbone D.J., Hodges S. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impot Res 2003, 15:299-306.
17. Roehrborn C.G., Siami P., Barkin J., Damião R., Major-Walker K., Nandy I., et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 2010, 57:123-131.
18. Mills T.M., Lewis R.W. The role of androgens in the erectile response: a 1999perspective. Mol Urol 1999, 3:75-86.
19. Heim N., Hursch C.J. Castration for sex offenders: treatment or punishment? A review and critique of recent European literature. Arch Sex Behav 1979, 8:281-304.
20. Burris A.S., Banks S.M., Carter C.S., Davidson J.M., Sherins R.J. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992, 13:297-304.
21. Iversen P., Melezinek I., Schmidt A. Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function. BJU Int 2001, 87:47-56.
22. Schroder F.H., Collette L., de Reike T.M., Whelan P. Prostate cancer treated by anti-androgens: is sexual function preserved?. Br J Cancer 2000, 82:283-290. EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer.
23. Brock G.B., Lue T.F. Drug-induced male sexual dysfunction. An update. Drug Saf 1993, 8:414-426.
24. Finger W.W., Lund M., Slagle M.A. Medications that may contribute to sexual disorders: a guide to assessment and treatment in family practice. J Fam Pract 1997, 44:33-43.
25. Ekselius L., von Knorring L. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol 2001, 21:154-160.
26. Labbate L.A., Grimes J.B., Arana G.W. Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders. Biol Psychiatry 1998, 43:904-907.
27. Montejo A.L., Llorca G., Izquierdo J.A., Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022outpatients. J Clin Psychiatry 2001, 62:10-21. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
28. Giuliano F., Clement P. Pharmacology for the treatment of premature ejaculation. Pharm Rev 2012, 64:621-644.
29. Labbate L.A., Croft H.A., Oleshansky M.A. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry 2003, 64:11-19.
30. Rosen R.C., Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 2003, 64:5-10.
31. Hensley P.L., Nurnberg H.G. Depression. Women's sexual function and dysfunction: study, diagnosis and treatment 2006, 619-626. Taylor and Francis, Abingdon. I. Goldstein, C. Meston, S. Davis, A. Traish (Eds.).
32. Seagraves R., Balloon R. Sexual pharmacology: fast facts 2003, WW Norton & Company, New York.
33. Clayton A.H., Warnock J.K., Kornstein S.G., Pinkerton R., Sheldon-Keller A., McGarvey E.L. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004, 65:62-67.
34. Keltner N.L., McAfee K.M., Taylor C.L. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care 2002, 38:111-116.
35. Serretti A., Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol 2011, 26:130-140.
36. Calabrò R.S., Marino S., Bramanti P. Sexual and reproductive dysfunction associated with antiepileptic drug use in men with epilepsy. Expert Rev Neurother 2011, 11:887-895.
37. Kaufman K.R., Struck P.J. Gabapentin-induced sexual dysfunction. Epilepsy Behav 2011, 21:324-326.
38. Ahlskog J.E. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease. Physiol Behav 2011, 104:168-172.
39. Giuliano F. Tramadol for the treatment of premature ejaculation. Eur Urol 2012, 61:744-745.
40. Merits M.J., Beckerman I., de Varies E.G., van deer Zee A.G., ten Hoor K.A., van der Graaf W.T., et al. Tamoxifen effects on subjective and psychosexual well being, in a randomized breast cancer study comparing high-dose and standard dose chemotherapy. Br J Cancer 2002, 86:1546-1550.
41. Kwan K.W., Chlebowski R.T. Sexual dysfunction and aromatase inhibitor use in survivors of breast cancer. Clin Breast Cancer 2009, 9:219-224.